Skip to content
BidBenchmark

Contract award

LEIDOS BIOMEDICAL RESEARCH INC

IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
PIID
HHSN26100019
Award key
CONT_AWD_HHSN26100019_7529_HHSN261201500003I_7529
Recipient UEI
HV8BH9BPG8Y9
Parent award
CONT_IDV_HHSN261201500003I_7529
Source as of
Current award value
$27,474,9223
Obligated to date
$27,474,9222
Potential with options
$27,474,9223
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Frederick, Maryland
Set-aside
None
Pricing
Cost No Fee
Competition
Not Competed
Period of performance
Sep 19, 2016Sep 18, 2021Through Sep 18, 2021 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 15, 2016Initial award$14,738,374.00$27,474,922.00
1Jan 13, 2017M$0.00$27,474,922.00
2Aug 10, 2017C$12,669,444.00$27,474,922.00
3Sep 27, 2018M$67,104.00$27,474,922.00
P00004Mar 2, 2021M$0.00$27,474,922.00
P00005Jun 10, 2021M$0.00$27,474,922.00
P00006Dec 20, 2021M$0.00$27,474,922.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 28, 2026usaspending_contract_csv@2026.08.24b9aecd3398b
contractor_idUSAspending.govAug 28, 2026usaspending_contract_csv@2026.08.24b9aecd3398b
current_award_valueUSAspending.govAug 28, 2026usaspending_contract_csv@2026.08.24b9aecd3398b
naics_codeUSAspending.govAug 28, 2026usaspending_contract_csv@2026.08.24b9aecd3398b
potential_award_valueUSAspending.govAug 28, 2026usaspending_contract_csv@2026.08.24b9aecd3398b
psc_codeUSAspending.govAug 28, 2026usaspending_contract_csv@2026.08.24b9aecd3398b
total_obligatedUSAspending.govAug 28, 2026usaspending_contract_csv@2026.08.24b9aecd3398b

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 7 transaction records parsed from USAspending.gov, retrieved Aug 28, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
HHSN26100019 — LEIDOS BIOMEDICAL RESEARCH INC · BidBenchmark